New York, NY, United States of America

Avinash Desai

This inventor holds 1 USPTO granted patent. Top assignee: Actinium Pharmaceuticals, Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avinash Desai. Retrieved from https://idiyas.com/inventor/avinash-desai-27w7e5k3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Avinash Desai: Innovator in Cancer Treatment

Introduction

Avinash Desai is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative work. His dedication to advancing medical science is evident in his patent portfolio.

Latest Patents

Avinash holds a patent titled "Radioconjugates Targeting CD33 in the Treatment of Cancers." This patent represents a crucial step in developing targeted therapies for cancer patients, showcasing his commitment to improving treatment options.

Career Highlights

Avinash is currently employed at Actinium Pharmaceuticals, Limited. His role at the company allows him to work on groundbreaking research and development projects aimed at enhancing cancer therapies. His expertise and innovative mindset contribute to the company's mission of providing effective treatments.

Collaborations

Avinash collaborates with talented professionals in the field, including his coworker Mary M Chen. Together, they work towards advancing cancer treatment solutions and share a common goal of improving patient outcomes.

Conclusion

Avinash Desai is a dedicated inventor whose work in cancer treatment is making a significant impact. His patent and contributions at Actinium Pharmaceuticals highlight his commitment to innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…